JP Stock MarketDetailed Quotes
4883 Modalis Therapeutics
- 102
- +2+2.00%
20min DelayMarket Closed Dec 23 15:30 JST
7.08BMarket Cap-1.32P/E (Static)
102High95Low4.94MVolume99Open100Pre Close481.80MTurnover20352wk High7.94%Turnover Ratio69.40MShares6252wk Low-64.98EPS TTM6.34BFloat Cap4070Historical HighLossP/E (Static)62.16MShs Float62Historical Low-77.24EPS LYR7.00%Amplitude--Dividend TTM5.19P/B100Lot Size--Div YieldTTM
Modalis Therapeutics Key Stats
EPS
According to the latest financial report of Modalis Therapeutics, the latest earnings per share (TTM) for the company is -8.41. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Modalis Therapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Modalis Therapeutics shows that the company's current ratio is 12.91, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Modalis Therapeutics, the quick ratio is 12.38, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Modalis Therapeutics? The latest ROE figure is -30.41%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Modalis Therapeutics, the total asset return on investment (ROA) is -21.76%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Modalis Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Modalis Therapeutics, the net profit margin is -1.08K%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Heat List
JP
Overall
Symbol
Price
% Chg
No Data